tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Ultragenyx assumed with a Buy at H.C. Wainwright

H.C. Wainwright assumed coverage of Ultragenyx (RARE) with a Buy rating and $80 price target The firm sees an attractive buying opportunity with the shares down 35% year-to-date. The Orbit trial did not fail and the final top-line result is risk-mitigated and should deliver favorable data, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1